Skip to main content
Clinical Trials/CTRI/2024/05/068030
CTRI/2024/05/068030
Recruiting
Phase 4

Comparison of Externaloblique intercostal Planeblock vs port site infiltration in laparoscopic right donor nephrectomy

ParkaviV1 site in 1 country54 target enrollmentStarted: June 2, 2024Last updated:

Overview

Phase
Phase 4
Status
Recruiting
Sponsor
ParkaviV
Enrollment
54
Locations
1
Primary Endpoint
To evaluate the analgesic effect of Externaloblique intercostal Planeblock with 0.5% Ropivacaine in laproscopic right donor nephrectomy.

Overview

Brief Summary

This is a prospective compartive study comparing the analgesic effect of external oblique intercostal Planeblock  vs local infiltration in patients undergoing laparoscopic right donor nephrectomy.The study will be conducted in Kovai Medical Center and Hospital, Coimbatore.After getting informed written consent from the patients ,they will divided into 2 groups. One will be receiving External oblique intercostal Planeblock and the other will receive local infiltration at port  site. Primary outcome is  analgesic effect of block will be assessed using Numerical rating scale . Secondary outcome is effect of block in reducing the usage of opioids postoperatively.

Study Design

Study Type
Interventional
Allocation
Na

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age above 18 and below 70 Physical status classification:ASA1and ASA2 Both male and female Patients who are willing to participate.

Exclusion Criteria

  • Patients refusal Allergic to local anaesthetic History of multiple previous abdominal surgery.

Outcomes

Primary Outcomes

To evaluate the analgesic effect of Externaloblique intercostal Planeblock with 0.5% Ropivacaine in laproscopic right donor nephrectomy.

Time Frame: Pain is evaluated using Numerical rating scale at the time of extubation and at 1 hr, 3 hrs, 6 hrs, 12 hrs after extubation

Secondary Outcomes

  • To determine the efficacy of external oblique intercostal Planeblock & local infiltration in reducing the usage of opioids(Opioids usage time is noted at 3,6,12 hrs after extubation)

Investigators

Sponsor
ParkaviV
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

ParkaviV

Kovai Medical Center and Hospital

Study Sites (1)

Loading locations...

Similar Trials